Identification of differentially expressed proteins in human glioblastoma cell lines and tumors

Abstract

KEY WORDSproteomics; matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF); liquid chromatography tandem mass spectrometry (LC-MS-MS); glioblastoma; U87MG; major vault protein; cystatin B; Hsp27; tissue transglutaminase; epidermal growth factor receptor ABSTRACT An in-frame deletion of 801 bp in exons 2-7 (type III mutation) of the epidermal growth factor receptor (EGFR) is detected at high incidence in primary glioblastoma tumors. A proteomic approach was used to generate differential protein expression maps of fetal human astrocytes (FHA), human glioblastoma cell lines U87MG and U87MG expressing type III EGFR deletion (U87MG⌬EGFR) that confers high malignancy to tumor cells. Two-dimensional gel electrophoresis followed by in-gel digestion of separated spots and protein identification by LC-MS-MS and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) identified 23 proteins expressed at higher levels or exclusively in FHA and 29 proteins expressed at higher levels or exclusively in U87MG cells. Three proteins, ubiquitin, cystatin B, and tissue transglutaminase (TTG), were upregulated in U87MG⌬EGFR relative to U87MG. Four proteins highly expressed by U87MG cells, Hsp27, major vault protein, TTG, and cystatin B, were analyzed by Western blot, ELISA, or RT-PCR in cell extracts and in tissue samples of glioblastoma multiforme (GBM; grade IV), low-grade astrocytomas (grades I and II), and nonmalignant brain lesions. All four proteins were highly expressed in GBM tissues compared to nonmalignant brain. These proteins may be used as diagnostic or functional (e.g., multiple drug resistance, invasiveness) markers for glioblastoma tumors. GLIA 42:194 -208, 2003.

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment

“…The data revealed distinct differences between radiotherapy-treated and untreated glial tumours in an experimental glioma animal model. Significant differences were also detected between glioma and normal brain, which is consistent with previous studies on both glioma (Zhang et al, 2003;Iwadate et al, 2004) and other types of tumours (Melle et al, 2004). It is obvious that our method permits tumour progression to be monitored over time, since protein profiles from different time points during tumour growth formed subgroups in score space when modelled with PCA.…”

Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-κB Inactivation

“…Drug resistance is a complex process that involves hundreds of changes in gene expressions. To date, many types of proteins have been identified that are altered in drug-resistant cells, such as membrane proteins (35), proteins associated with glutathione transferases and detoxification (28), and proteins of the DNA repair system (36). From the perspective of transcriptional regulation, it has been shown that chemotherapy activates NF-nB, which results in resistance to apoptosis (37).…”

Low-Temperature Approach to Highly Emissive Copper Indium Sulfide Colloidal Nanocrystals and Their Bioimaging Applications

“…This EGFRvIII mutation confers enhanced tumorgenicity in vivo, 61 and there is differential expression of the EGFR protein compared to the U87MG parental cell line. 62 Cells were harvested by trypsinization in EDTA/trypsin, washed in PBS, and centrifuged three times at 200 g for 2 min. Cell number was determined and mice were anesthetized with isofluorane anesthesia and the scalp was swabbed with alcohol.…”